PHARMACOGENETICS OF DRUGS USED IN ANAESTHESIA = PHARMACOGENETIQUE DES PRODUITS UTILISES EN ANESTHESIEKALOW W.1973; EXCERPTA MED., INTERNATION. CONGR. SER.; PAYS-BAS; DA. 1973; NO 250; PP. 415-427; BIBL. 3P.; (C.R. IVE CONGR. INT. GENET. HUM.; PARIS; 1971)Conference Paper

THE METABOLISM OF XENOBIOTICS IN DIFFERENT POPULATIONSKALOW W.1982; CAN. J. PHYSIOL. PHARMACOL.; ISSN 0008-4212; CAN; DA. 1982; VOL. 60; NO 1; PP. 1-12; ABS. FRE; BIBL. 3 P.Article

Pharmacogenetics : its biologic roots and the medical challengeKALOW, W.Clinical pharmacology and therapeutics. 1993, Vol 54, Num 3, pp 235-241, issn 0009-9236Article

The Pennsylvania State University College of Medicine, 1990 Bernard B. Brodie lecture. Pharmacogenetics : past and futureKALOW, W.Life sciences (1973). 1990, Vol 47, Num 16, pp 1385-1397, issn 0024-3205, 13 p.Article

Genetic variation in the human hepatic cytochrome P-450 systemKALOW, W.European journal of clinical pharmacology. 1987, Vol 31, Num 6, pp 633-641, issn 0031-6970Article

Variability of caffeine metabolism in humansKALOW, W.Arzneimittel-Forschung. 1985, Vol 35, Num 1A, pp 319-324, issn 0004-4172Article

Both populations and individuals are evolutionary targets: pharmacogenomic and cultural indicatorsKALOW, W.Pharmacogenomics journal (Print). 2002, Vol 2, Num 1, pp 12-14, issn 1470-269XArticle

SALIVARY EXCRETION OF AMOBARBITAL IN MAN.INABA T; KALOW W.1975; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1975; VOL. 18; NO 5; PP. 558-562; BIBL. 13 REF.Article

DEFICIENT METABOLISM OF DEBRISOQUINE AND SPARTEINEINABA T; OTTON SV; KALOW W et al.1980; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1980; VOL. 27; NO 4; PP. 547-549; BIBL. 12 REF.Article

N-HYDROXYLATION OF PENTOBARBITAL IN MAN.TANG BK; INABA T; KALOW W et al.1977; DRUG METABOL. DISPOSIT.; U.S.A.; DA. 1977; VOL. 5; NO 1; PP. 71-74; BIBL. 6 REF.Article

METABOLIC FATE OF PHENOBARBITAL IN MAN: N-GLUCOSIDE FORMATIONTANG BK; KALOW W; GREY AA et al.1979; DRUG METABOL. DISPOSIT.; USA; DA. 1979; VOL. 7; NO 5; PP. 315-318; BIBL. 16 REF.Article

N-DEMETHYLATION OF COCAINE IN THE RAT AND IN ISOLATED RAT HEPATOCYTES: COMPARISON WITH AMINOPYRINE DEMETHYLATIONSTEWART DJ; INABA T; KALOW W et al.1978; J. PHARMACOL. EXPER. THERAPEUT.; USA; DA. 1978; VOL. 207; NO 1; PP. 171-177; BIBL. 20 REF.Article

AMOBARBITAL METABOLISM IN MAN: N-GLUCOSIDE FORMATIONTANG BK; KALOW W; GREY AA et al.1978; RES. COMMUNIC. CHEM. PATHOL. PHARMACOL.; USA; DA. 1978; VOL. 21; NO 1; PP. 45-53; BIBL. 14 REF.Article

ISOLATION AND IDENTIFICATION OF 5-ACETYLAMINO-6-FORMYLAMINO-3-METHYLURACIL AS A MAJOR METABOLITE OF CAFFEINE IN MANTANG BK; GRANT DM; KALOW W et al.1983; DRUG METABOLISM AND DISPOSITION; ISSN 0090-9556; USA; DA. 1983; VOL. 11; NO 3; PP. 218-220; BIBL. 14 REF.Article

POLYMORPHIC N-ACETYLATION OF A CAFFEINE METABOLITEGRANT DM; TANG BK; KALOW W et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 33; NO 3; PP. 355-359; BIBL. 30 REF.Article

VARIABILITY IN CAFFEINE METABOLISMGRANT DM; TANG BK; KALOW W et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 33; NO 5; PP. 591-602; BIBL. 42 REF.Article

DEBRISOQUINE HYDROXYLATION CAPACITY: PROBLEMS OF ASSESSMENT IN TWO POPULATIONSINABA T; OTTON SV; KALOW W et al.1981; CLIN. PHARMACOL. THER.; ISSN 0009-9236; USA; DA. 1981; VOL. 29; NO 2; PP. 218-223; BIBL. 17 REF.Article

DISTRIBUTION OF SERUM PARAOXON HYDROLYZING ACTIVITIES IN A CANADIAN POPULATIONCARRO CIAMPI G; KADAR D; KALOW W et al.1981; CAN. J. PHYSIOL. PHARMACOL.; ISSN 0008-4212; CAN; DA. 1981; VOL. 59; NO 8; PP. 904-907; ABS. FRE; BIBL. 5 REF.Article

IDENTIFICATION OF P(4')-HYDROXYANTIPYRINE AS A METABOLITE OF ANTIPYRINE IN MANINABA T; UCHINO H; KALOW W et al.1981; RES. COMMUN. CHEM. PATHOL. PHARMACOL.; ISSN 0034-5164; USA; DA. 1981; VOL. 33; NO 1; PP. 3-8; BIBL. 6 REF.Article

ANTIPYRINE METABOLISM IN THE RAT BY THREE HEPATIC MONOOXYGENASESINABA T; LUCASSEN M; KALOW W et al.1980; LIFE SCI.; GBR; DA. 1980; VOL. 26; NO 23; PP. 1977-1983; BIBL. 21 REF.Article

GENETIC STUDY OF AMOBARBITAL ELIMINATION BASED ON ITS KINETICS IN TWINS.ENDRENYI L; INABA T; KALOW W et al.1976; CLIN. PHARMACOL. THERAPEUT.; U.S.A.; DA. 1976; VOL. 20; NO 6; PP. 701-714; BIBL. 1 P. 1/2Article

MYOTONIA ASSOCIATED WITH SMALL CELL CARCINOMA OF THE LUNG.HUMPHREY JG; HILL ME; GORDON AS et al.1976; ARCH. NEUROL.; U.S.A.; DA. 1976; VOL. 33; NO 5; PP. 375-377; BIBL. 3 REF.Article

COMPARATIVE PHARMACOGENETICS OF SPARTEINE AND DEBRISOQUINEINABA T; VINKS A; OTTON SV et al.1983; CLINICAL PHARMACOLOGY AND THERAPEUTICS; ISSN 0009-9236; USA; DA. 1983; VOL. 33; NO 3; PP. 394-399; BIBL. 17 REF.Article

ANTIPYRINE METABOLITES IN TWO POPULATIONSINABA T; UCHINO H; KADAR D et al.1981; RES. COMMUN. CHEM. PATHOL. PHARMACOL.; ISSN 0034-5164; USA; DA. 1981; VOL. 32; NO 2; PP. 235-244; BIBL. 2 P.Article

A METHOD FOR STUDYING DRUG METABOLISM IN POPULATIONS: RACIAL DIFFERENCES IN AMOBARBITAL METABOLISMKALOW W; TANG BK; KADAR D et al.1979; CLIN. PHARMACOL. THERAPEUT.; USA; DA. 1979; VOL. 26; NO 6; PP. 766-776; BIBL. 29 REF.Article